Titre :

Prevalence and management of chronic breathlessness in COPD in a tertiary care center

Auteur(s) :

Carette, H. [Auteur]
Zysman, M. [Auteur]
Institut Mondor de Recherche Biomédicale [IMRB]
Morélot-Panzini, C. [Auteur]
CHU Pitié-Salpêtrière [AP-HP]
Perrin, J. [Auteur]
Gomez, E. [Auteur]
Guillaumot, A. [Auteur]
Burgel, P. [Auteur]
Hôpital Cochin [AP-HP]
Université Sorbonne Paris Cité [USPC]
Deslée, G. [Auteur]
Hôpital Maison Blanche
Surpas, P. [Auteur]
Le Rouzic, O. [Auteur]
Institut Pasteur de Lille
Centre d’Infection et d’Immunité de Lille - INSERM U 1019 - UMR 9017 - UMR 8204 [CIIL]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Perez, T. [Auteur]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Institut Pasteur de Lille
Centre d’Infection et d’Immunité de Lille - INSERM U 1019 - UMR 9017 - UMR 8204 [CIIL]
Chaouat, A. [Auteur]
Roche, N. [Auteur]
Chabot, F. [Auteur]
Hôpital Cochin [AP-HP]
Université Sorbonne Paris Cité [USPC]

Titre de la revue :

BMC Pulmonary Medicine

Pagination :

95

Éditeur :

BioMed Central

Date de publication :

2019-12

ISSN :

1471-2466

Mot(s)-clé(s) en anglais :

Breathlessness
Chronic obstructive pulmonary disease
Doctors ‘attitude
Opioid

Discipline(s) HAL :

Sciences du Vivant [q-bio]
Sciences du Vivant [q-bio]/Médecine humaine et pathologie
Sciences du Vivant [q-bio]/Médecine humaine et pathologie/Pneumologie et système respiratoire

Résumé en anglais : [en]

BACKGROUND : Breathlessness is the prominent symptom of chronic obstructive pulmonary disease (COPD). Despite optimal therapeutic management including pharmacological and non-pharmacological interventions, many COPD patients ...
Lire la suite >BACKGROUND : Breathlessness is the prominent symptom of chronic obstructive pulmonary disease (COPD). Despite optimal therapeutic management including pharmacological and non-pharmacological interventions, many COPD patients exhibit significant breathlessness. Chronic breathlessness is defined as breathlessness that persists despite optimal treatment of the underlying disease. Because of the major disability related to chronic breathlessness, symptomatic treatments including opioids have been recommended by several authors. The prevalence of chronic breathlessness in COPD and its management in routine clinical practice have been poorly investigated. Our aim was to examine prevalence, associated characteristics and management of chronic breathlessness in patients with COPD recruited in a real-life tertiary hospital-based cohort.METHODS : A prospective study was conducted among 120 consecutive COPD patients recruited, in stable condition, at Nancy University Hospital, France. In parallel, 88 pulmonologists of the same geographical region were asked to respond to an on-line questionnaire on breathlessness management.RESULTS : Sixty four (53%) patients had severe breathlessness (modified Medical Research Council scale≥3), despite optimal inhaled medications for 94% of them; 40% had undergone pulmonary rehabilitation within the past 2 years. The severity of breathlessness increased with increasing airflow limitation. Breathlessness was associated with increased symptoms of anxiety, depression and with osteoporosis. No relation was found with other symptoms, exacerbation rate, or cardiovascular comorbidities. Among the patients with chronic breathlessness and Hospitalized Anxiety and/or Depression score > 10, only 25% were treated with antidepressant or anxiolytic. Among the pulmonologists 46 (52%) answered to the questionnaire and expressed a high willingness to prescribe opioids forchronic breathlessness, which contrasted with the finding that none of these patients received such treatments against breathlessness.CONCLUSION : Treatment approaches to breathlessness and associated psychological distress are insufficient in COPD. This study highlights underuse of pulmonary rehabilitation and symptomatic treatment for breathlessness.Lire moins >

Langue :

Anglais

Comité de lecture :

Oui

Audience :

Internationale

Vulgarisation :

Non

Collections :

• Centre d'Infection et d'Immunité de Lille (CIIL) - U1019 - UMR 9017

Source :

Harvested from HAL